Stroke & Vascular Disorders
Neoplastic and infectious aneurysms
Dec. 29, 2024
Worddefinition
At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas.
Arachnoid cyst …
- Updated 12.22.2023
- Released 09.13.1995
- Expires For CME 12.22.2026
Arachnoid cyst
Introduction
Overview
Arachnoid cysts are one of the most common incidental findings on brain MRI. They are usually intracranial and supratentorial in location, but spinal and even intraneural cysts may be identified and possibly cause symptoms or confound medical decision-making. Most cysts are solitary, and the presence of multiple cysts should prompt an evaluation for glutaric aciduria type 1, which is present in 25% of bitemporal cases. Most asymptomatic cysts do not require active management or surveillance. The exceptions are discussed in this article. In the presence of symptoms, surgical evaluation and intervention are recommended. The indications, risks, and advantages of these approaches are discussed in detail herein.
Key points
|
• Be certain that the cyst is responsible for symptoms before considering intervention. Over 70% of pediatric and over 90% of adult cases have no attributable symptoms. | |
|
• Arachnoid cysts in children are more likely to present with hydrocephalus. Cyst resolution or shrinkage is more common than growth after the first year of life. | |
|
• For suprasellar arachnoid cysts, endocrinopathies, such as precocious puberty and growth hormone deficiency, are common manifestations in children. | |
|
• There may be rupture of bridging veins or vessels in the cyst’s wall, which can result in a subdural hematoma or bleeding into the cyst. | |
|
• Endoscopic procedures for temporobasal arachnoid cysts have the highest failure rate (81%), highest recurrence (19%), and highest complication rate (24%). | |
|
• Cysts larger than 5 cm have a higher risk of rupture; however, a systematic review of published literature did not find evidence to support recommending against participation in sports for patients with arachnoid cysts. |
Historical note and terminology
Although clear cysts along the neuraxis have been described on autopsies throughout the centuries (31), the earliest modern description of arachnoid cysts is ascribed to Bright in 1831 (10). Prior to the mid-20th century consolidation of the terminology, arachnoid cysts were referred to under a variety of terms, such as "meningitis serosa circumscripta," “chronic cystic arachnoiditis," "cerebral pseudotumor," or "leptomeningeal cyst” (65). Arachnoid cysts can be best described as non-neoplastic fluid collections that lie between two membranes of arachnoid mater--a thin inner and a collagen-reinforced outer membrane. Thus, arachnoid cysts would be most properly described as intra-arachnoid cysts.
Although there is no standard nomenclature, arachnoid cysts can be classified by symptoms, etiology (primary or developmental vs. secondary), embryological origin (eg, expansion of the roof plate of the brain vesicle), localization, or communication with CSF pathways.
There had been a historical debate whether arachnoid cysts are primary malformations of the arachnoid (65) or secondary to hypoplasia or agenesis of the underlying brain (55). The debate settled over the past half-century, when the diagnosis of arachnoid cysts shifted from an autopsy or surgical diagnosis to a radiologic diagnosis that is mostly made incidentally with no concurrent cortical hypoplasia noted.
One of the first successful surgical interventions for an arachnoid cyst was a partial removal by Placzek and Krause in 1907, resulting in clinical improvement (46). Traditional surgical resection of the cyst wall (38) was often complicated by damage to the surrounding brain and cyst recurrence. Over time, the successes with shunting the recurrent cysts led to shunt insertion becoming a primary treatment approach in the 1980s (66).
Clinical manifestations
Presentation and course
The clinical manifestations of arachnoid cysts are nonspecific and depend on their location along the neuraxis as well as the age at presentation. The majority of arachnoid cysts are intracranial, and they are noted on 1% to 2% of brain MRIs (26; 71; 02; 49). Most arachnoid cysts are asymptomatic and identified incidentally. Intracranial arachnoid cysts most frequently arise in the middle cranial fossa (34%), retrocerebellar region (33%), and cerebral convexity (14%), but they can occur anywhere from within the ventricles to the interhemispheric space (02). Midline cysts tend to present earlier in life with signs and symptoms of hydrocephalus (03). Most cysts are solitary. Only 2% to 5% of patients have multiple cysts, which are often noted in the context of genetic disorders (02). Most importantly, bitemporal arachnoid cysts occur in association with glutaric aciduria type 1 in up to 25% of cases. Urine should be checked for glutaric acid in cases of bitemporal arachnoid cysts, as general anesthesia can exacerbate metabolic derangements and, thus, pose significant risk of harm with surgeries (36).
Table 1. Clinical Characteristics of Intracranial Arachnoid Cysts in Children and Adults
|
Children |
Adults | |||
|
Incidental (72%) |
Symptomatic (28%) |
Incidental (92%) |
Symptomatic (8%) | |
|
Mean age |
7.5 years (15% infant) |
6 years (40% infant) |
54 years |
51 years |
|
Sex |
80% male |
63% male |
56% male |
39% male |
|
Presenting symptoms |
Headaches (26%) |
Headaches (44%) |
Headaches (25%) |
Headaches (61%) |
|
Evidence of hydrocephalus |
2.5% |
44% |
0.5% |
14% |
|
Location |
Middle fossa 47% |
Middle fossa 36% |
Middle fossa 44% |
Middle fossa 29% |
|
Multiple |
3% |
2.5% |
0% |
2% |
|
Imaging follow up |
Stable 86% |
Cyst rupture and resolution 3% |
Stable 95% |
Cyst rupture and resolution 7% |
|
Intervention |
Surgery 2% |
Surgery 94% |
Surgery 0.3% |
Surgery 89% |
|
| ||||
There is a clear difference in the rate of symptomatic presentation and the type of symptoms children and adults exhibit. Most arachnoid cysts are discovered incidentally for general symptoms most commonly evaluated in the population, such as headaches.
In children, about 28% of these cysts do have symptoms attributed to them, which are usually sequelae of elevated intracranial pressure, such as headaches, macrocephaly, or intractable emesis. A particularly intriguing presentation in children is "bobblehead doll syndrome." This occurs in suprasellar arachnoid cysts and consists of a head-bobbing motion due to neck tremor, typically in the context of intraventricular CSF flow obstruction. About 70% of bobblehead doll syndrome cases are caused by suprasellar or third ventricular cysts (52).
Endocrine abnormalities, such as precocious puberty and growth hormone deficiency, may be seen in children both at presentation and on follow-up. In a pediatric cohort of 44 mainly symptomatic patients, three had precocious puberty, and one had amenorrhea at presentation. Long-term follow-up of this cohort revealed new endocrinopathies in 38% of the patients who underwent operation and 25% of those who did not. Besides precocious puberty, growth hormone deficiency was the most common abnormality (33).
A significant proportion of children are diagnosed with arachnoid cyst while undergoing epilepsy evaluation (23). It is contentious whether arachnoid cysts actually cause seizures or are simply a "flag" that there is some coexisting process in the underlying brain (eg, hypoplasia). Nevertheless, the presence of an abnormal co-localizing ictal or interictal EEG or imaging, such as hypoperfusion or hypometabolism, will often influence the decision to treat surgically (68).
In adults, the rate of symptomatic cysts is about 3.5 times lower than in children. Besides headache evaluations, incidental cysts are discovered during stroke or transient ischemic attack, vertigo or tinnitus, and, less commonly, seizure evaluations (23). They may also be discovered after traumatic injuries, such as those associated with motor vehicle accidents. The main difference in symptomatic presentation in adults compared to children is the higher prevalence of cranial nerve dysfunction in adults (39%), which is usually linked to posterior fossa location. Subtle cognitive deficits may be identified in patients with left temporal arachnoid cysts (75). A preoperative case-control study found that patients with arachnoid cysts had more neurocognitive deficits on tests of verbal fluency and the Tower test than a control group admitted for spinal surgery; postoperatively, improvements were only seen in the group with arachnoid cysts (22). Similar findings were described in another series of 22 patients, with depression and anxiety being overrepresented in the arachnoid cyst population and with symptomatic improvement after shunting (21). There are numerous case reports linking psychosis to the presence of arachnoid cysts (06). This may be merely coincidental with the relatively high prevalence of both psychiatric illness and arachnoid cysts, and the frequent central nervous imaging of patients with psychiatric or neurologic symptoms.
Spinal arachnoid cysts may be intradural or extradural. The symptoms from spinal arachnoid cysts are progressive lower limb weakness, spasticity, radicular pain, scoliosis, and recurrent urinary tract infection. Cases with acute presentations or intermittent symptoms and signs are well described (76). In general, children with spinal arachnoid cysts present with motor deficit (76%), although 25% had back pain only (16).
Intraneural arachnoid cysts situated within the sheath of cranial nerves are an extremely rare manifestation described in the context of cranial nerve palsy (09).
Prognosis and complications
The observed natural history of arachnoid cysts differs significantly between children (especially infants) and adults. These age group differences are most likely the combined result of concurrent brain growth, cyst locations that may lead to earlier symptom development, and cyst resolution in children versus a higher incidence of unrelated comorbidities prompting brain-imaging and de novo cyst development later in life for adults.
In children, a study evaluating patients aged five years or younger found that 80% of significant arachnoid cyst enlargement happens in the first year of life, and no cyst expansions are noted in the 3- to 5-year-old group (32). Similar observations were made by another pediatric natural history study showing a lack of cases with enlargement beyond age four years (02). These findings link the most rapid postnatal brain growth phase to cyst enlargement. Longitudinally, these studies showed stable lesion size in most patients and a 10% to 23% risk for cyst enlargement, but also potential for cyst regression, in 4% to 10% of patients (32; 02). The latter might explain the decreasing prevalence of arachnoid cysts with age in both pediatric and adult cohorts (71; 32; 02).
In adults, untreated asymptomatic arachnoid cysts have a very low enlargement potential. In two natural history studies with average follow-up periods of 2.5 to 4 years, 95% to 97% of cysts remained stable in size, and 0% to 2.3% enlarged, whereas 1% to 5% reduced in volume or even resolved completely (02; 23). Case series on resolution of arachnoid cysts clearly indicated a much lesser potential for resolution in adults and patients with larger cysts (57). Care should be taken when attributing a patient's symptoms to the presence of the cyst, which is often a matter of debate. Extrapolating from the natural history data, the risk of symptom development is less than 0.25% per year in adults (02; 23). There may be rupture of bridging veins or vessels in the cyst wall, which can result in a subdural hematoma or bleeding into the cyst (56; 60). Chronic hematomas are found in approximately 5% of patients with an arachnoid cyst (74). It has been estimated that arachnoid cysts are present in 2.5% of patients with chronic subdural hematomas (44). A case-control study found larger cyst size (greater than 5 cm) and head injury to be significant risk factors for cyst rupture or hemorrhage, although these hematomas may occur spontaneously as well (13). In these instances of arachnoid cysts associated with extra-axial hematoma, it may be sufficient to surgically address the hematoma without resecting the arachnoid cyst if there are no symptoms specifically associated with the cyst itself (79). From a series of 60 cases of middle cranial fossa arachnoid cysts treated by various measures, it appears that small effusions can be treated conservatively, and in cases in which surgical intervention is considered necessary, burr hole and subdural drainage are effective in most cases (64). Cyst-related mortalities are extremely rare (47).
Clinical vignette
A 61-year-old obese male presented with a 2-month history of episodic lightheadedness and mild headache. Lightheaded episodes lasted 5 to 10 minutes and could occur up to three to four times per day. On examination, there were no neurologic signs except for a moderately elevated blood pressure of 180/100 and grade 2 hypertensive changes on fundoscopy.
Investigations. A brain MRI without contrast showed a 3 to 4 cm left middle cranial fossa arachnoid cyst without mass effect. Urea and electrolytes, liver function, thyroid function, full blood count, and erythrocyte sedimentation rate were normal. The ECG met voltage criteria for hypertension. An EEG was normal, and a 24-hour EEG was normal, despite one symptomatic episode. Lumbar puncture found normal pressure and constituents. Repeated blood pressure measurements showed diastolic recordings of up to 120 mm/Hg. A chest x-ray was normal. Further investigation of hypertension did not reveal any cause.
Outcome. The patient began hypertension treatment with a beta-blocker, and he had resolution of his headaches and lightheadedness within 24 hours. No symptoms were present at the follow-up three months later. No intervention was performed to address the arachnoid cyst as the patient’s symptoms responded to medical management of his hypertension.
Biological basis
Etiology and pathogenesis
Most arachnoid cysts are developmental, and their exact etiology is unknown, but they can also be acquired after trauma or infection through CSF entrapment within arachnoid adhesions. The developmental hypothesis is corroborated by cysts identified on routine prenatal sonography (14). Cases followed from infancy have shown no hypoplasia at birth but, instead, the development of hypoplasia and expansion of the cyst with the passage of time (43). Some electron microscopy studies demonstrate that the inner sheath is composed of several layers of arachnoid cells, with underlying connective tissue rich in desmosomes and tight junctions as well as intermixed collagen fibers and myofibrils (40). However, an electron microscopic study of 24 symptomatic arachnoid cysts from different sites showed that the cyst walls varied in structure, with some composed of normal arachnoid (50%), some composed of a core of dense fibrous material with simple epithelial lining, and others with nonarachnoid luminal epithelium with microvilli and cilia (eg, ependyma), cilia, and nervous tissue, suggesting formation at early embryonal development as a teratological phenomenon (50).
A number of hypotheses explain the formation or expansion of arachnoid cysts. These include (1) cystic trapping of fluid due to the hypoplasia of adjacent brain; (2) an osmotic gradient caused by microhemorrhages drawing fluid into the cyst; (3) a slit valve mechanism causing unidirectional CSF flow into the cyst driven by brain pulsation, coughing, or Valsalva maneuver; or (4) active CSF secretion by ependymal-like cells into the cyst (07).
Secondary arachnoid cysts can occur after epidural anesthesia, overdrainage of CSF via ventriculoperitoneal shunts, spinal injury or surgery (27), head trauma or radiosurgery (41), craniotomy (37), phenol injection (54), or use of oil-based contrast media (62). Of the 17 neonatal cases of anterior cervical arachnoid cysts reported in the literature, 65% have had either prior myelomeningocele repair or a history of spinal trauma (25). There have been cases of cervicothoracic arachnoid cysts associated with obstetric brachial plexus palsy (39). Epidural spinal arachnoid cysts occur through small dural defects, in much the same manner as secondary arachnoid cysts.
The direct link between supratentorial arachnoid cysts in epileptogenesis is debated. The literature suggests inconsistent localization with epileptic foci on EEG (05; 77); however, there are cases where the epileptic foci colocalize with the arachnoid cyst, and cyst resection leads to resolution of seizures (11).
Epidemiology
Arachnoid cysts are identified in any age group, from routine prenatal sonography (14) to diagnostic imaging in older adults (71). The exact prevalence of arachnoid cysts is unknown. In large-scale prevalence studies on brain MRIs, arachnoid cysts were noted in 2.2% of the pediatric patients (26), 1.1% in the older adults (71), and 1.4% in the general adult population (02). In children, arachnoid cysts are twice as common in boys (03) but appear to have a more even sex distribution in the elderly (78). Temporal lobe cysts are more commonly found on the left side (2.5:1), and there seems to be a significant male preponderance of temporal arachnoid cysts (p< 0.004). For all other sites, there does not appear to be any sex predilection, apart from the cerebellar pontine angle, which may be more common in women (24).
A few genetic syndromes predispose to arachnoid cysts. Perhaps the clinically most important of these is glutaric aciduria type 1, which, if undetected, can pose a life-threatening risk in the context of general anesthesia (36). Other syndromes include spinal extradural arachnoid cysts, which may rarely be familial and associated with lymphedema-distichiasis syndrome and FOXC2 mutations; furthermore, arachnoid cysts in the brain are also more common in patients with tuberous sclerosis (5.5% vs. 0.5% general population) (42; 08). Intraspinal arachnoid cysts are commonly associated with other congenital abnormalities (48).
It has also been reported that arachnoid cysts can occur after stereotactic radiosurgery. These arachnoid cysts are extratumoral and can arise following treatment. They are histologically different from intratumoral cysts that form secondary to hemorrhagic change within the tumor (41).
Prevention
There is no known specific method to prevent or even indicate the need to prevent arachnoid cysts, even in the secondary (posttraumatic or inflammatory) setting.
Differential diagnosis
Confusing conditions
The clinical differential diagnoses of symptomatic intracranial arachnoid cysts include other causes of increased intracranial pressure, headaches, or cranial nerve palsy. Radiographic differential diagnoses include any cystic intracranial lesion, such as epidermoid cyst, subdural hygroma or chronic subdural hemorrhage, cystic neoplasms such as pleomorphic xanthoastrocytoma and hemangiopericytoma, and non-neoplastic cysts, like porencephalic, neurenteric or neuroglial cysts, expanded Virchow-Robin spaces and neurocysticercosis and brain abscesses.
In the spinal canal, the differential diagnosis includes any other cause of cord or root compression, such as a tumor (particularly ependymoma or hemangioblastoma), hematoma, infection, disc herniation, spinal epidermoid cyst, spinal dermoid cyst, spinal endodermal cyst, spinal hydatid cyst, and spinal cysticercosis. In the sacral region, the differential diagnosis includes meningoceles or secretory cysts of the nerve root pockets (eg, Tarlov cysts).
Associated or underlying disorders
Bilateral cranial temporal arachnoid cysts are associated with a higher incidence of glutaric aciduria type 1. As noted earlier, spinal extradural arachnoid cysts can be associated with lymphedema-distichiasis syndrome and FOXC2 mutations.
Diagnostic workup
These cysts are usually noted on CT or MRI evaluations but may also be noted on prenatal ultrasonography. The gold standard for diagnostics is conventional T1- and T2-weighted FLAIR MRI combined with diffusion-weighted MRI (12). On MRI, arachnoid cysts have well-demarcated, smooth walls and content consistent with CSF signal in all sequences. On magnetic resonance imaging (MRI), the arachnoid cysts have the same signal intensity as CSF on T1 (dark signal), T2 (high signal), T2-FLAIR (dark signal), and diffusion (dark signal). On the apparent diffusion coefficient (ADC) maps, the cyst has a similar high apparent diffusion coefficient value as CSF.
The presence of contrast enhancement, a nodular component, complex wall, heterogeneous FLAIR signal within the cyst, or diffusion restriction is highly indicative of alternative diagnoses. Prior to the wide availability of these techniques, cisternography with water-soluble intrathecal contrast was used to help identify the well-defined borders of an arachnoid cyst from the irregular surface of an epidermoid. This technique is now rarely used and mainly restricted to preoperative evaluations.
Suprasellar arachnoid cysts are often seen on axial neuroimaging studies as rounded areas with imaging characteristics of cerebrospinal fluid located just behind the frontal horns of the lateral ventricles. The three structures resemble the head of a rabbit or "Mickey Mouse," depending on the degree of hydrocephalus. Suprasellar arachnoid cysts cause vertical displacement of the optic chiasm or tracts, upward deflection of the rostral mesencephalon and mammillary bodies, and effacement of the ventral pons (73). Cine-balanced steady-state free precession MRI (bSSFP) can correctly demonstrate communication between arachnoid cysts and the subarachnoid space in 92% compared with operative findings (35). In cases of parasellar arachnoid cysts, preoperative evaluation should include assessment of the hypothalamic-pituitary axis. There may be deficiencies in growth hormone and thyrotropin or stimulation of the hypothalamic-pituitary axis with giantism and obesity (01).
Middle cranial fossa cysts have been categorized based on cyst size (18). Galassi type 1 cysts, which are limited to the anterior part of the temporal fossa and do not cause appreciable mass effect, account for 20% of middle fossa arachnoid cysts. Approximately 50% of middle fossa arachnoid cysts are type 2 cysts, where the cyst occupies the anterior and middle temporal fossa and there may be moderate mass effect. The remaining 30% are type 3 cysts, wherein the cyst occupies the temporal fossa almost completely, the temporal pole is severely atrophic, with compression of the frontal and parietal lobes and striking mass effect.
Bilateral temporal arachnoid cysts may occur in association with glutaric aciduria type 1 in up to 25% of cases. These are usually male infants presenting with signs of encephalopathy; however, less severe symptomatic presentations of the disorder may be seen. Thus, urine should be checked for glutaric acid in cases of bitemporal arachnoid cysts because even simple operations may be risky (36). Neuropsychological testing can occasionally reveal cognitive deficits, and these can correspond to the temporal hypometabolism and blood flow on PET (61; 80). The PET scan abnormalities recover postoperatively, and, in some cases, rather vague preoperative symptoms can improve (61). Intrathecal gadolinium-enhanced MR may also assist in the selection of cases of intracranial arachnoid cyst for surgery (67).
Intraspinal arachnoid cysts are usually readily identified by MRI (53).
Management
Because the natural history of a majority of arachnoid cysts is uneventful, a conservative approach for management can often be used. Asymptomatic cysts have a low rate of cyst enlargement on follow-up imaging, which supports not routinely imaging these patients. When a watch-and-wait policy was adopted in 111 children under the age of 18 years, the size of arachnoid cyst remained stable in 87 (78%), increased in 11 (10%), and decreased in 13 (12%). Patients with symptomatic cysts are significantly younger and more likely to have associated hydrocephalus. An increase in size and the need for surgical intervention was observed more often in young children, and no patient older than four years of age at the time of initial diagnosis became symptomatic or had an increase in cyst size (03).
A decision to intervene surgically depends on the presence or absence of hydrocephalus. Although imaging characteristics of hydrocephalus can be used for guidance, patients may be symptomatic without signs of mass effect from the arachnoid cyst. In such instances, parenchymal fiberoptic transducers could be used with a relatively low complication risk for prolonged intracranial pressure monitoring to aid the decision whether to intervene, even in asymptomatic patients (69). A trial of acetazolamide, which reduces CSF production, could also be used to find which patients may benefit from surgical decompression. One study demonstrated encouraging results, with 94% of patients who responded to the acetazolamide challenge benefiting from surgery (30).
In the presence of hydrocephalus and elevated intracranial pressure, a ventriculo-cysto-peritoneal shunt is preferred (51; 45). In contrast, in the absence of hydrocephalus, the preferred operation is to fenestrate the cyst, producing connections between the cyst and the ventricle, or basal cisterns (17; 29). Endoscopic techniques to fenestrate arachnoid cysts with or without stereotactic guidance are increasingly being used (58; 28; 63; 15; 19; 59).
Cyst aspiration produces early improvement, but recollection almost always occurs. Recurrence is more common when the arachnoid cyst is complex or is associated with multi-compartmental hydrocephalus. With recurrent sellar and suprasellar arachnoid cysts, stereotactic radiosurgery has been used, but the long-term effects are still to be proven (70). In cases with extra-axial hematoma without any symptoms associated with the cyst itself, it may be sufficient to surgically address the hematoma without resecting the arachnoid cyst (79).
An analysis of pooled data comparing four different neurosurgical techniques (open craniotomy for cyst excision, open craniotomy for cyst fenestration, endoscopic fenestration, or cystoperitoneal shunting) found similar success rates in general, but with individual differences, and supported a personalized treatment strategy for cases requiring surgery (04).
In most cases of ventriculo-cysto-peritoneal shunt, hydrocephalus and endocrine symptoms will resolve, but shunt failure with frequent shunt revisions is common (72). A follow-up study of 110 children with intracranial arachnoid cysts treated surgically demonstrated clinical improvement in 87% of patients and radiological improvement in 93% after endoscopic surgery, even higher frequencies of improvement after open microsurgery, and 89% after shunt operations (34).
Spinal subarachnoid cysts can often be surgically excised. Data from a small series of patients undergoing surgical management for extradural spinal arachnoid cysts suggest that symptoms such as lower limb weakness and pain improve in most patients undergoing cyst excision and closure of any dural defect (20).
Special considerations
Pregnancy
There is no evidence that pregnancy influences the growth potential of arachnoid cysts.
Anesthesia
The precautions related to anesthesia are the same as those for any intracranial surgery.
Neurologic clearance
Unless there is evidence of mass effect, patients with arachnoid cysts do not require neurologic clearance to undergo other, unrelated invasive procedures.
Pediatric age group
Some researchers have postulated that individuals with arachnoid cysts may have a higher rate of structural brain injury after trauma, especially if the cysts measure 5 cm or larger (13). However, a systematic review of published case reports for individuals with arachnoid cysts who suffered a structural brain injury during a sport or recreational activity did not find consistent evidence to support recommending against participation in sports for patients with arachnoid cysts (81). As such, patients with arachnoid cysts have no contraindication against their participation in sports, although parents and children should be counseled appropriately regarding the possibility of brain injury following trauma.
Media
References
- 01
- Adan L, Bussieres L, Dinand V, Zerah M, Peirre-Kahn A, Brauner R. Growth, puberty and hypothalamic-pituitary function in children with suprasellar arachnoid cyst. Eur J Pediatr 2000;159(5):348-55. PMID 10834520
- 02
- Al-Holou WN, Terman S, Kilburg C, et al. Prevalence and natural history of arachnoid cysts in adults. J Neurosurg 2013; 118(2):222-31. PMID 23140149
- 03
- Al-Holou WN, Yew AY, Boomsaad ZE, Garton HJ, Muraszko KM, Maher CO. Prevalence and natural history of arachnoid cysts in children. J Neurosurg Pediatr 2010;5(6):578-85. PMID 20515330
- 04
- Ali ZS, Lang SS, Bakar D, Storm PB, Stein SC. Pediatric intracranial arachnoid cysts: comparative effectiveness of surgical treatment options. Childs Nerv Syst 2014;30(3):461-9. PMID 24162618
- 05
- Arroyo S, Santamaria J. What is the relationship between arachnoid cysts and seizure foci. Epilepsia 1997;38:1098-102. PMID 9579956
- 06
- Baquero GA, Molero P, Pla J, Ortuño F. A schizophrenia-like psychotic disorder secondary to an arachnoid cyst remitted with neurosurgical treatment of the cyst. Open Neuroimag J 2014;8:1-4. PMID 24653786
- 07
- Basaldella L, Orvieto E, Dei Tos AP, Della Barbera M, Valente M, Longatti P. Causes of arachnoid cyst development and expansion. Neurosurg Focus 2007;22(2):E4. PMID 17608347
- 08
- Boronat S, Caruso P, Auladell M, Van Eeghen A, Thiele EA. Arachnoid cysts in tuberous sclerosis complex. Brain Dev 2014;36(9):801-6. PMID 24325802
- 09
- Brewington D, Petrov D, Whitmore R, Liu G, Wolf R, Zager EL. De novo intraneural arachnoid cyst presenting with complete third nerve palsy: case report and literature review. World Neurosurg 2017;98:873.e27-e31. PMID 27923759
- 10
- Bright R. Reports and medical cases. Vol 2. In: Longman, Rees, Orme, Brown, editors. Diseases of the brain and nervous system. Part 1. London: Highley, 1831:437-9.
- 11
- Broekx S, Vandevenne J, Weyns F. Exploring the controversial association between intracranial arachnoid cysts and epileptogenesis: a case report and review of the literature. SN Comp Clini Med 2020;2:2482-8.
- 12
- Bukte Y, Paksoy Y, Genç E, Uca AU. Role of diffusion-weighted MR in differential diagnosis of intracranial cystic lesions. Clin Radiol 2005;60(3):375-83. PMID 15710142
- 13
- Cress M, Kestle JR, Holubkov R, Riva-Cambrin J. Risk factors for pediatric arachnoid cyst rupture/hemorrhage: a case-control study. Neurosurgery 2013;72(5):716-22. PMID 23313978
- 14
- De Keersmaecker B, Ramaekers P, Claus F, et al. Outcome of 12 antenatally diagnosed fetal arachnoid cyst: case series and review of the literature. Eur J Paediatr Neurol 2015;19(2):114-21. PMID 25599983
- 15
- Di Rocco F, R James S, Roujeau T, Puget S, Sainte-Rose C, Zerah M. Limits of endoscopic treatment of sylvian arachnoid cysts in children. Childs Nerv Syst 2010;26(2):155-62. PMID 19823848
- 16
- Evangelou P, Meixenberger J, Bernhard M, et al. Operative management of idiopathic spinal intradural arachnoid cysts in children: a systematic review. Childs Nerv Syst 2013;29(4):657-64. PMID 23224408
- 17
- Fewel ME, Levy ML, McComb JG. Surgical treatment of 95 children with 102 intracranial arachnoid cysts. Pediatr Neurosurg 1996;25:165-73. PMID 9293543
- 18
- Galassi E, Tognetti F, Gaist G, Fagioli L, Frank F, Frank G. CT scan and metrizamide CT cisternography in arachnoid cysts of the middle cranial fossa: classification and pathophysiological aspects. Surg Neurol 1982;17:363-6. PMID 7089853
- 19
- Gangemi M, Seneca V, Colella G, Cioffi V, Imperato A, Maiuri F. Endoscopic versus microsurgical cyst excision and shunting for treating intracranial arachnoid cysts. J Neurosurg Pediatr 2011;8(2):158-64. PMID 21806357
- 20
- Garg K, Borkar SA, Kale SS, Sharma BS. Spinal arachnoid cysts - our experience and review of literature. Br J Neurosurg 2017;31(2):172-8. PMID 28287894
- 21
- Gjerde PB, Litleskare S, Lura NG, Tangen T, Helland CA, Wester K. Anxiety and depression in patients with intracranial arachnoid cysts-a prospective study. World Neurosurg 2019;132:e645-53. PMID 31442638
- 22
- Gjerde PB, Schmid M, Hammar A, Wester K. Intracranial arachnoid cysts: impairment of higher cognitive functions and postoperative improvement. J Neurodev Disord 2013;5(1):21. PMID 23985219
- 23
- Hall S, Smedley A, Sparrow O, et al. Natural history of intracranial arachnoid cysts. World Neurosurg 2019;126:e1315-20. PMID 30898748
- 24
- Helland CA, Lund-Johansen M, Wester K. Location, sidedness, and sex distribution of intracranial arachnoid cysts in a population-based sample. J Neurosurg 2010;113(5):934-9. PMID 20095787
- 25
- Jain F, Chaichana KL, McGirt MJ, Jallo GI. Neonatal anterior cervical arachnoid cyst: case report and review of the literature. Childs Nerv Sys 2008;24(8):965-70. PMID 18338174
- 26
- Jansen PR, Dremmen M, van den Berg A, et al. Incidental findings on brain imaging in the general pediatric population. N Engl J Med 2017;377(16):1593-5. PMID 29045203
- 27
- Jean WC, Keene CD, Haines SJ. Cervical arachnoid cysts after craniocervical decompression for Chiari II malformations: report of three cases. Neurosurgery 1998;43:941-4. PMID 9766324
- 28
- Kamikawa S, Inui A, Tamaki N, Kobayashi N, Yamadori T. Application of flexible neuroendoscopes to intracerebroventricular arachnoid cysts in children: use of videoscopes. Minim Invasive Neurosurg 2001;44(4):186-9. PMID 11830774
- 29
- Kang JK, Lee KS, Lee IW, et al. Shunt independent surgical treatment of middle cranial fossa arachnoid cysts in children. Childs Nerv Syst 2000;16(2):111-6. PMID 10663819
- 30
- Kershenovich A, Toms SA. The acetazolamide challenge: a tool for surgical decision making and predicting surgical outcome in patients with arachnoid cysts. J Neurol Surg A Cent Eur Neurosurg 2017;78(1):33-41. PMID 27415592
- 31
- Kivela T, Pelkonen R, Oja M, Heiskanen O. Diabetes insipidus and blindness caused by a suprasellar tumor: Pieter Pauw's observations from the 16th century. JAMA 1998;279(1):48-50. PMID 9424043
- 32
- Lee JY, Kim JW, Phi JH, Kim SK, Cho BK, Wang KC. Enlarging arachnoid cyst: a false alarm for infants. Childs Nerv Syst 2012;28(8):1203-11. PMID 22383163
- 33
- Lee JY, Lee YA, Jung HW, et al. Long-term endocrine outcome of suprasellar arachnoid cysts. J Neurosurg Pediatr 2017;19(6):696-702. PMID 28338427
- 34
- Lee EJ, Ra YS. Clinical and neuroimaging outcomes of surgically treated intracranial cysts in 110 children. J Korean Neurosurg Soc 2012;52(4):325-33. PMID 23133720
- 35
- Li AE, Wilkinson MD, McGrillen KM, Stoodley MA, Magnussen JS. Clinical applications of cine balanced steady-state free precession MRI for the evaluation of subarachnoid spaces. Clin Neuroradiol 2015;25(4):349-60. PMID 25854921
- 36
- Lutcherath V, Waaler PE, Jellum E, Wester K. Children with bilateral temporal arachnoid cysts may have glutaric aciduria type 1 (GAT1); operation without knowing that may be harmful. Acta Neurochir 2000;142(9):1025-30. PMID 11086812
- 37
- Martinez-Lage JF, Lopez F, Poza M. Arachnoid cysts as a complication of ventricular shunting. Childs Nerv Syst 1991;7(6):356-7. PMID 1764713
- 38
- Matson DD. Neurosurgery of infancy and childhood. Ed 2. Springfield: Charles C. Thomas, 1969:185.
- 39
- Miravet E, Sinisterra S, Birchansky S, et al. Cervicothoracic extradural arachnoid cyst: possible association with obstetric brachial plexus palsy. J Child Neurol 2002;17(10):770-2. PMID 12546433
- 40
- Miyagami M, Tsubokawa T, Kasahara E, Kagawa Y, Miyazaki S. Ultrastructural findings of arachnoid cysts and epithelial cysts. Brain Nerve 1991;43(6):545-53. PMID 1910938
- 41
- Murakami K, Jokura H, Kawagishi J, Watanabe M, Tominaga T. Development of intratumoral cyst or extra-tumoral arachnoid cyst in intracranial schwannomas following gamma knife radiosurgery. Acta Neurochir (Wien) 2011;153(6):1201-9. PMID 21369949
- 42
- Ogura Y, Yabuki S, Iida A, et al. FOXC2 mutations in familial and sporadic spinal extradural arachnoid cyst. PLoS One 2013;8(11):e80548. PMID 24278289
- 43
- Okumura Y, Sakaki T, Hirabayashi H. Middle cranial fossa arachnoid cyst developing in infancy: case report. J Neurosurg 1995;82:1075-7. PMID 7760183
- 44
- Parsch CS, Krauss J, Hofmann E, Meixensberger J, Roosen K. Arachnoid cysts associated with subdural hematomas and hygromas: analysis of 16 cases, longterm follow-up, and review of the literature. Neurosurgery 1997;40(3):483-90. PMID 9055286
- 45
- Pascual-Castroviejo I, Arcas J, Roche MC, Garcia Blazquez M, Martinez Bermejo A. Primary intracranial arachnoidal cysts. A study of 67 childhood cases. Childs Nerv Syst 1991;7(5):257-63. PMID 1933926
- 46
- Placzek S, Krause F. Zur Kenntnis der umschriebenen Arachnitis adhesiva cerebralis. Berliner klin Wochenschr 1907;29:1-13.
- 47
- Prezerakos GK, Kouyialis AT, Ziaka DS, Boviatsis EJ. Sudden death due to 4th ventricle arachnoid cyst. Ir J Med Sci 2011;180(3):769-70. PMID 21279460
- 48
- Rabb CH, Raffel C, McComb JG, Kennedy JG. Spinal arachnoid cysts in the pediatric age group: an association with neural tube defects. J Neurosurg 1992;77(3):369-72. PMID 1506883
- 49
- Rabiei K, Jaraj D, Marlow T, Jensen C, Skoog I, Wikkelsø C. Prevalence and symptoms of intracranial arachnoid cysts: a population-based study. J Neurol 2016;263(4):689-94. PMID 26860092
- 50
- Rabiei K, Tisell M, Wikkelso C, Johansson BR. Diverse arachnoid cyst morphology indicates different pathophysiological origins. Fluids Barriers CNS 2014;11(1):5. PMID 24581284
- 51
- Raffel CR, McComb JG. To shunt or fenestrate: which is the best surgical treatment for arachnoid cysts in pediatric patients. Neurosurgery 1988;23:338-42. PMID 3226511
- 52
- Renne B, Rueckriegel S, Ramachandran S, Radic J, Steinbok P, Singhal A. Bobble-head doll syndrome: report of 2 cases and a review of the literature, with video documentation of the clinical phenomenon. J Neurosurg Pediatr 2018;21(3):236-46. PMID 29303456
- 53
- Rimmelin A, Clouet PL, Salatino S, et al. Imaging of thoracic and lumbar spinal extradural arachnoid cysts: report of two cases. Neuroradiology 1997;39:203-6. PMID 9106295
- 54
- Rincon F, Mocco J, Komotar RJ, Khandji AG, McCormick PC, Olarte M. Chronic myelopathy due to a giant spinal arachnoid cyst: a complication of intrathecal injection of phenol. J Neurosurg Spine 2008;8(4):390-3. PMID 18377326
- 55
- Robinson RG. The temporal lobe agenesis syndrome. Brain 1964;88:87-106. PMID 14152215
- 56
- Rogers MA, Siu KH, Klug GL. Middle cranial fossa in association with subdural haematoma. A review and recommendations for management. Br J Neurosurg 1990;4(6):497-502. PMID 2076211
- 57
- Russo N, Domenicucci M, Beccaglia MR, Santoro A. Spontaneous reduction of intracranial arachnoid cysts: a complete review. Br J Neurosurg 2008;22(5):626-9. PMID 19016115
- 58
- Schroeder HW, Gaab MR. Neuroendoscopic treatment of arachnoid cysts. In: Jimenez DF editor. Intracranial endoscopic neurosurgery. Lebanon, NH: AANS Publications Office, 1998:111-23.
- 59
- Schulz M, Kimura T, Akiyama O, et al. Endoscopic and microsurgical treatment of Sylvian fissure arachnoid cysts - clinical and radiological outcome. World Neurosurg 2015;84(2):327-36. PMID 25818148
- 60
- Sener RN. Arachnoid cysts associated with post-traumatic and spontaneous rupture into the subdural space. Comput Med Imaging Graph 1997;21:341-4. PMID 9690007
- 61
- Sgouros S, Chapman S. Congenital middle fossa arachnoid cysts may cause global brain ischaemia: a study with 99Tc-hexamethylpropyleneamineoxime single photon emission computerised tomography scans. Pediatr Neurosurg 2001;35(4):188-94. PMID 11694796
- 62
- Shah J, Patkar D, Parmar H, Prasad S, Varma R. Arachnoiditis associated with arachnoid cyst formation and cord tethering following myelography: magnetic resonance features. Australas Radiol 2001;45(2):236-9. PMID 11380373
- 63
- Shim KW, Lee YH, Park EK, Park YS, Choi JU, Kim DS. Treatment option for arachnoid cysts. Childs Nerv Syst 2009;25(11):1459-66. PMID 19536550
- 64
- Sprung C, Armbruster B, Koeppen D, Cabraja M. Arachnoid cysts in the middle cranial fossa accompanied by subdural effusions - experience with 60 consecutive cases. Acta Neurochir 2011;153(1):75-84. PMID 20931240
- 65
- Starkman SP, Brown TC, Linell SA. Cerebral arachnoid cysts. J Neuropathol Exp Neurol 1958;17:484-500. PMID 13564260
- 66
- Stein SC. Intracranial developmental cysts in children: treatment by cystoperitoneal shunting. Neurosurgery 1981;8:647-50. PMID 7279150
- 67
- Tali ET, Ercan N, Kaymaz M, Pasaoglu A, Jinkins JR. Intrathecal gadolinium (gadopentetate dimeglumine)-enhanced MR cisternography used to determine potential communication between the cerebrospinal fluid pathways and intracranial arachnoid cysts. Neuroradiology 2004;46(9):744-54. PMID 15289956
- 68
- Tamburrini G, Dal Fabbro M, Di Rocco C. Sylvian fissure arachnoid cysts: a survey on their diagnostic workout and practical management. Childs Nerv Sys 2008;24(5):593-604. PMID 18305944
- 69
- Tamburrini G, Di Rocco C, Velardi F, Santini P. Prolonged intracranial pressure (ICP) monitoring in non-traumatic pediatric neurosurgical diseases. Med Sci Monit 2004;10(4):MT53-63. PMID 15039654
- 70
- Thompson TP, Lunsford LD, Kondziolka D. Successful management of sellar and suprasellar arachnoid cysts with stereotactic intracavitary irradiation: an expanded report of four cases. Neurosurgery 2000;46(6):1518-22. PMID 10834657
- 71
- Vernooij MW, Ikram MA, Tanghe HL, et al. Incidental findings on brain MRI in the general population. N Engl J Med 2007;357(18):1821-8. PMID 17978290
- 72
- Voormolen JH. Arachnoid cysts of the middle cranial fossa. Clin Neurol Neurosurg 1992;94:176-9. PMID 1320504
- 73
- Wang JC, Heier L, Souweidane MM. Advances in the endoscopic management of suprasellar arachnoid cysts in children. J Neurosurg 2004;100(5 Suppl Pediatrics):418-26. PMID 15287448
- 74
- Wester K, Helland CA. How often do chronic extracerebral haematomas occur in patients with intracranial arachnoid cysts. J Neurol Neurosurg Psychiat 2008;79(1):72-5. PMID 17488784
- 75
- Wester K, Hugdahl K. Arachnoid cysts of the left temporal fossa: impaired preoperative cognition and postoperative improvement. J Neurol Neurosurg Psychiatry 1995;9:293-8. PMID 7673959
- 76
- Wong CW, Lee ST, Lui TN, Wu T, Wu LL. Fluctuating hemiparesis caused by a quadrigeminal arachnoid cyst: case report. Surg Neurol 1996;45(2):193-5. PMID 8607073
- 77
- Yalcin AD, Oncel C, Kaymaz A, Kuloğlu N, Forta H. Evidence against association between arachnoid cysts and epilepsy. Epilepsy Res 2002;49(3):255-60. PMID 12076847
- 78
- Yamakawa H, Niikawa S, Ohkuma A, Kobayashi H, Hattori T. Primary intracranial arachnoid cyst in the elderly: a survey of 39 cases in the elderly. Acta Neurochir (Wien) 1991;113(1-2):42-7. PMID 1799142
- 79
- Yuksel MO, Gurbuz MS, Senol M, Karaarslan N. Spontaneous subdural haematoma developing secondary to arachnoid cyst rupture. J Clin Diagn Res 2016;10(10):PD05-6. PMID 27891397
- 80
- Zaatreh MM, Bates ER, Hooper SR, et al. Morphometric and neuropsychologic studies in children with arachnoid cysts. Pediatr Neurol 2002;26(2):134-8. PMID 11897478
- 81
- Zuckerman SL, Prather CT, Yengo-Kahn AM, Solomon GS, Sills AK, Bonfield CM. Sport-related structural brain injury associated with arachnoid cysts: a systematic review and quantitative analysis. Neurosurg Focus 2016;40(4):E9.** PMID 27032926
Contributors
All contributors' financial relationships have been reviewed and mitigated to ensure that this and every other article is free from commercial bias.
Authors
-
David Olayinka Kamson MD PhD
Dr. Kamson of Johns Hopkins Medical has no relevant financial relationships to disclose.
See Profile -
Sushant Puri MBBS
Dr. Puri of Johns Hopkins Hospital has no relevant financial relationships to disclose.
See Profile
Editor
-
Rimas V Lukas MD
Dr. Lukas of Northwestern University Feinberg School of Medicine received honorariums from Novartis and Novocure for speaking engagements, honorariums from Cardinal Health, Novocure, and Merck for advisory board membership, and research support from BMS as principal investigator.
See Profile
Former Authors
- Jacob Young MD
- Nicholas Butowski MD
- Robert Grant MD
Patient Profile
- Age range of presentation
-
- 0 month to 65+ years
- Sex preponderance
-
- male>female, >2-4:1
- Heredity
-
- heredity may be a factor
- Population groups selectively affected
-
- none
- Occupation groups selectively affected
-
- none
ICD & OMIM codes
- ICD-9
-
- Arachnoid cyst: 348.0
- Arachnoid cyst of spine: 349.2
- ICD-10
-
- Cerebral cysts: G93.0
- Arachnoid cyst of spine: G96.19
- OMIM
-
- Intracranial arachnoid cysts: 207790
This is an article preview.
Start a Free Account
to access the full version.
-
Nearly 3,000 illustrations, including video clips of neurologic disorders.
-
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
-
Full spectrum of neurology in 1,200 comprehensive articles.
-
Listen to MedLink on the go with Audio versions of each article.
Questions or Comment?
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Also in This Category
-
-
Neuro-Oncology
NF2-related schwannomatosis
Dec. 13, 2024
-
Neuro-Oncology
Tumors of the skull base
Dec. 05, 2024
-
Neuro-Oncology
Ganglioglioma
Oct. 15, 2024
-
Neuro-Oncology
Paraneoplastic syndromes
Oct. 15, 2024
-
Neuro-Oncology
Overview of neuropathology updates for infiltrating gliomas
Oct. 11, 2024
-
Neuro-Oncology
NTRK-fused tumors of the central nervous system
Oct. 07, 2024
-
Neuro-Oncology
Anti-LGI1 encephalitis
Oct. 03, 2024